Mij
Senior Member (Voting Rights)
Multidisciplinary study uses blood samples to identify disease years early, including cancers, heart disease, and autoimmune disorders
New York, NY(March 02, 2026)
What if doctors could tell you a disease was coming years before you felt a single symptom—and stop it in its tracks? That is the goal of a sweeping new research initiative launched by the Icahn School of Medicine at Mount Sinai in collaboration with the Uniformed Services University of the Health Sciences (USU) and the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF).
The project, called “ORIGIN: Omics to Characterize Preclinical Stages of Non-Infectious Diseases,” brings together 10 specialties across Mount Sinai Health System in an ambitious multidisciplinary disease-prevention study.
The study will analyze stored blood samples from up to 13,000 active-duty U.S. service members, drawn years before any diagnosis, using advanced molecular “omics” tools such as proteomics, exposomics, metabolomics, genomics, and more. By identifying risk factors and early warning signals, ORIGIN aims to lay the groundwork for predicting and ultimately preventing some of today’s most common and devastating diseases.
New York, NY(March 02, 2026)
What if doctors could tell you a disease was coming years before you felt a single symptom—and stop it in its tracks? That is the goal of a sweeping new research initiative launched by the Icahn School of Medicine at Mount Sinai in collaboration with the Uniformed Services University of the Health Sciences (USU) and the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF).
The project, called “ORIGIN: Omics to Characterize Preclinical Stages of Non-Infectious Diseases,” brings together 10 specialties across Mount Sinai Health System in an ambitious multidisciplinary disease-prevention study.
The study will analyze stored blood samples from up to 13,000 active-duty U.S. service members, drawn years before any diagnosis, using advanced molecular “omics” tools such as proteomics, exposomics, metabolomics, genomics, and more. By identifying risk factors and early warning signals, ORIGIN aims to lay the groundwork for predicting and ultimately preventing some of today’s most common and devastating diseases.